Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046260 · ClinicalTrials.gov registry record
Prospective Study to Assess a Diagnostic Aid for Cancer
A clinical trial of Cancer, sponsored by Harbinger Health.
- Recruiting
- Registry status
- 1,650
- Enrollment target
- 20
- Study locations
NCT07046260 is a study of Cancer that is actively recruiting participants, run by Harbinger Health. The registered enrollment target is 1,650 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (53% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT07046260, a study of Cancer, is actively recruiting participants, sponsored by Harbinger Health.
- RECRUITING
- Registry status
- 1,650 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.
Conditions Studied
Interventions
- OTHER Blood sample collection
Study Locations (20)
Florida
- Zoyla Almeida, MD PA - Coconut Creek
- Azzi ENT and Facial Reconstructive Surgery - Jupiter
- Prophase, LLC - Margate
- Millennium Medical Research - Miami
- Regis Clinical Research - Miami
- Gastroenterology of Greater Orlando - Orange City
- Millennium Physician Group - Port Charlotte
- Stuart Oncology Associates - Stuart
- Avita Clinical Research - Tampa
California
- Southern California Research Center - Coronado
- Palomar Health - Poway
- South Coast Gynecologic Oncology - San Diego
Georgia
- Cancer Center of Middle Georgia - Dublin
- Pulmonary & Sleep Specialists of Northeast Georgia, P.C - Winder
Illinois
- Christie Clinic - Champaign
- Hope and Healing Cancer Services - Hinsdale
Colorado
- Rocky Mountain Gastroenterology - Centennial
Iowa
- Iowa Clinic - West Des Moines
Kansas
- Hutchinson Clinic - Hutchinson
Louisiana
- Northlake Gastroenterology Associates - Hammond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,650 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07046260
The ClinicalTrials.gov registry entry for NCT07046260 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (53% lower). The listed sponsor is Harbinger Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood sample collection is the first listed.
NCT07046260 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT07046260 about?
NCT07046260 is a clinical study titled "Prospective Study to Assess a Diagnostic Aid for Cancer". The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.
What is the current status of trial NCT07046260?
This trial is currently recruiting. The enrollment target is 1,650 participants. The study started on 2025-07-11. Estimated completion is 2026-11.
What conditions does trial NCT07046260 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT07046260?
The interventions under investigation include: Blood sample collection (OTHER).
Who is sponsoring clinical trial NCT07046260?
This trial is sponsored by Harbinger Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07046260 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.